Oncopeptides Competitors and Similar CompaniesClear all

Oncopeptides's competitors and similar companies include CureVac and Biocon.
Oncopeptides
Oncopeptides
Oncopeptides is a clinical development pharmaceutical company.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
Founding Date
Founding Date
2000
Founding Date
2000
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Stockholm, SE HQ
Stockholm, SE
Los Altos, US
Mountain View, US
Waltham, US
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Employees
Employees
80
Employees
82517% decrease
Employees
16,5612% increase
Valuation ($)
Valuation ($)
42.4 m
Valuation ($)
648.3 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
kr71.1m (FY, 2025)
Revenue (est.)
€535.2m (FY, 2024)
Revenue (est.)
₹167.8b (FY, 2026)
Cost of goods
Cost of goods
kr2.5m (FY, 2025)
Cost of goods
€9.7m (FY, 2024)
Cost of goods
₹56.9b (FY, 2026)
Gross profit
Gross profit
kr72m (FY, 2025)
Gross profit
€534.4m (FY, 2024)
Gross profit
₹115.8b (FY, 2026)
Net income
Net income
(kr249.6m) (FY, 2025)
Net income
€162.2m (FY, 2024)
Net income
₹3.7b (FY, 2026)
For sources of this data, please see the company profile

View Company Profiles

CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase

Biocon is a company that develops and manufactures biopharmaceutical products.

View company